A possible role for lutein and zeaxanthin in cognitive function in the elderly

American Journal of Clinical Nutrition

Volumn 96, Issue 5, 2012, Pages

  Johnson, Elizabeth J ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN;

AGE DISTRIBUTION; AGING; BRAIN LEVEL; COGNITION; DEMENTIA; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG POTENTIATION; EDUCATIONAL STATUS; GERIATRIC PATIENT; HUMAN; HYPERTENSION; LEARNING; MEMORY CONSOLIDATION; MILD COGNITIVE IMPAIRMENT; POPULATION RESEARCH; PRIMATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECALL; REVIEW; SEX DIFFERENCE; VERBAL BEHAVIOR; VERBAL FLUENCY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN; COGNITION; HUMANS; LUTEIN; XANTHOPHYLLS;

EID: 84867784644     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.034611     Document Type: Review

References (55)

1. Alzheimer's Association. 2010 Alzheimer's disease facts and figures. Chicago, IL: Alzheimer's Association National Office, 2010.
2. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol 2003;60:1385-9. (Pubitemid 37248799)
3. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield D, Markesbery WR. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005;64:1152-6.
4. Tarkowski E, Andreasen N, Tarkowski A, Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003;74:1200-5.
5. Teunissen CE, van Boxtel MPJ, Bosma H, Bosmans E, Delanghe J, De Bruijn C, Wauters A, Maes M, Jolles J, Steinbusch HWM, et al. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 2003;134:142-50. (Pubitemid 36054172)
6. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JCM, Breteler MMB. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol 2004;61:668-72. (Pubitemid 38637682)
7. Pappolla MA, Smith MA, Bryant-Thomas T, Bazan N, Petanceska S, Perry G, Thal LJ, Sano M, Refolo LM. Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. Free Radic Biol Med 2002;33:173-81. (Pubitemid 34775189)
8. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 2006;12:1005-15. (Pubitemid 44353380)
9. Praticò D. Alzheimer's disease and oxygen radicals: new insights. Biochem Pharmacol 2002;63:563-7. (Pubitemid 34457689)
10. Praticò D, Trojanowski JQ. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol Aging 2000;21:441-5; discussion 451-3.
11. McGeer PL, McGeer EG, Yasojima K. Alzheimer disease and neuroinflammation. J Neural Transm Suppl 2000;59:53-7. (Pubitemid 30479406)
12. Ravaglia G, Forti P, Maioli F, Brunetti N, Martelli M, Servadei L, Bastagli L, Bianchin M, Mariani E. Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers. J Gerontol A Biol Sci Med Sci 2005;60:1017-21. (Pubitemid 41233317)
13. Finkel T. Oxidants, oxidative stress and the biology of ageing. Nature 2000;408:239-47.
14. Sopher BL, Fukuchi K, Kavanagh TJ, Furlong CE, Martin GM. Neurodegenerative mechanisms in Alzheimer disease: a role for oxidative damage in amyloid beta protein precursor-mediated cell death. Mol Chem Neuropathol 1996;29:153-68. (Pubitemid 27016926)
15. Krinsky NI. Possible biologic mechanisms for a protective role of xanthophylls. J Nutr 2002;132:540S-2S. (Pubitemid 34208766)
16. Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Umezawa K, Ohno S, Oike Y, Ishida S. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 2007;27:2555-62. (Pubitemid 350158905)
17. Sasaki M, Ozawa Y, Kurihara T, Noda K, Imamura Y, Kobayashi S, Ishida S, Tsubota K. Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci 2009;50:1433-9.
18. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995;62(suppl):1448S-61S.
19. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PTVM, Nemesure B, Mitchell P, Kempen J. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol 2004;122:564-72. (Pubitemid 38456293)
20. Craft NE, Haitema TB, Garnett KM, Fitch KA, Dorey CK. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging 2004;8:156-62. (Pubitemid 38667940)
21. Johnson EJ, Vishwanathan R, Scott TM, Schalch W, Wittwer J, Hausman D, Davey A, Johnson MA, Green RC, Gearing M, et al. Serum carotenoids as a biomarker for carotenoid concentrations in the brain. FASEB J 2011;25 (abstr. 344.2).
22. Song JH, Fujimoto K, Miyazawa T. Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids fed DHA-containing oils. J Nutr 2000;130:3028-33. (Pubitemid 32005334)
23. Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med 2005;26:459-516. (Pubitemid 41741836)
24. Kritchevsky SB, Bush AJ, Pahor M, Gross MD. Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol 2000;152:1065-71.
25. Johnson EJ. Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr Rev 2005;63:9-15. (Pubitemid 40105628)
26. Gruszecki WI. Carotenoid orientation: role in membrane stabilization. In: Krinsky NI, Mayne ST, Sies H, eds. Carotenoids in health and disease. New York, NY: Marcel Dekker Inc, 2004:151-63.
27. Stahl W, Seis H. Effects of carotenoids and retinoids on gap junctional communication. Biofactors 2001;15:95-8. (Pubitemid 34455069)
28. Hammond BR Jr, Wooten BR. CFF thresholds: relation to macular pigment optical density. Ophthalmic Physiol Opt 2005;25:315-9. (Pubitemid 41702425)
29. Renzi LM, Hammond BR Jr. The relation between the macular carotenoids, lutein and zeaxanthin, and temporal vision. Ophthalmic Physiol Opt 2010;30:351-7.
30. Renzi LM, Hammond BR. The effect of macular pigment on heterochromatic luminance contrast. Exp Eye Res 2010;91:896-900.
31. Morris MC, Evans MD, Tangney CC, Bienias JL, Wilson RS. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology 2006;67:1370-6. (Pubitemid 44632059)
32. Lee L, Kang SA, Lee HO, Lee BH, Park JS, Kim JH, Jung IK, Park YJ, Lee JE. Relationships between dietary intake and cognitive function level in Korean elderly people. Public Health 2001;115:133-8. (Pubitemid 32266415)
33. Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo, MR, Navia B, Rivas T. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997;66:803-9. (Pubitemid 27415562)
34. Mangels AR, Holden JM, Beecher GR, Forman MR, Lanza E. Carotenoid content of fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc 1993;93:284-96. (Pubitemid 23070877)
35. Kang JH, Ascherio A, Grodstein F. Fruit and vegetable consumption and cognitive decline in aging women. Ann Neurol 2005;57:713-20. (Pubitemid 40628860)
36. Akbaraly NT, Faure H, Gourlet V, Favier A, Berr C. Plasma carotenoid levels and cognitive performance in an elderly population: results of the EVA Study. J Gerontol A Biol Sci Med Sci 2007;62:308-16. (Pubitemid 47065729)
37. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003;24:915-9. (Pubitemid 36962976)
38. Mecocci P, Polidori MC, Cherubini A, Ingegni TM, Mattioli PC, Catani M, Rinaldi P, Cecchetti R, Stahl W, Senin U, et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 2002;59:794-8. (Pubitemid 34517762)
39. Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res 1985;25:1531-5. (Pubitemid 16207358)
40. Wooten BR, Hammond BR, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 1999;40:2481-9. (Pubitemid 29455474)
41. Iannaccone A, Mura M, Gallaher KT, Johnson E, Todd WA, Kenyon E, Harris TL, Harris T, Satterfield S, Johnson KC, et al. Macular pigment optical density in the elderly: findings in a large biracial midsouth population sample. Invest Ophthalmol Vis Sci 2007;48:1458-65. (Pubitemid 351261325)
42. Gallaher KT, Mura M, Todd WA, Harris TL, Kenyon E, Harris T, Johnson KC, Satterfield S, Kritchevsky SB, Iannaccone A. Estimation of macular pigment optical density in the elderly: test-retest variability and effect of optical blur in pseudophakic subjects. Vision Res 2007;47:1253-9. (Pubitemid 46482630)
43. Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M, Ficek T. Macular pigment measurement by heterochromatic flicker photometry in older subjects: the Carotenoids and Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci 2004;45:531-8. (Pubitemid 38140511)
44. Mares JA, LaRowe T, Snodderly DM, Moeller SM, Gruber M, Klein M,Wooten B, Johnson E, Chapell R. Determinants of optical density of lutein and zeaxanthin in retinas of older women in the Age-Related Eye Disease Study (CAREDS), an ancillary study of the Women's Health Initiative. Am J Clin Nutr 2006;84:1107-22. (Pubitemid 44730382)
45. Renzi LM, Iannacocone A., Johnson E., Kritchevsky S. The relation between serum xanthophyllls, fatty acids, macular pigment and cognitive function in the Health ABC Study. FASEB J 2008;22:877.5.
46. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional manipulation of primate retinas. III. Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci 2005;46:692-702. (Pubitemid 40270354)
47. Park JH, Hwang HJ, Kim MK, Lee-Kim YC. Effects of dietary fatty acids and vitamin E supplementation on antioxidant vitamin status of the second generation rat brain sections. Korean J Nutr 2001;34:754-61.
48. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional manipulation of primate retinas. III. Effects of lutein or zeaxanthin supplementation on adipose and retina of xanthophylls-free monkeys. Invest Ophthalmol Vis Sci 2005;46:692-702. (Pubitemid 40270354)
49. Vishwanathan R, Neuringer M, Schalch W, Wittwer J, Johnson EJ. Lutein (L) and zeaxanthin (Z) levels in retina are related to levels in the brain. FASEB J 2011;25 (abstr. 344.1).
50. Miller LS, Stephen M, Meghan B, Woodard JL, Davey A, Martin P, Poon LW, Jazwinski SM, Green RC, Gearing M, et al. Cognitive performance in centenarians and the oldest old: norms from the Georgia Centenarian Study. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2010;17:575-90.
51. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia 1967;5:135-50.
52. McCarthy M, Ferris SH, Clark E, Crook T. Acquisition and retention of categorized material in normal aging and senile dementia. Exp Aging Res 1981;7:127-35. (Pubitemid 11060646)
53. Morris JC, Heyman A, Mohs RC, Hughe JP, van Belle G, Fillenbaum G, Mettits ED, Clark C. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-65. (Pubitemid 19239715)
54. Johansson B. The MIR - Memory-in-Reality Test. Stockholm, Sweden: Psykologiforlaget AB, 1988.
55. Johnson EJ, McDonald K, Caldarella SM, Chung H-Y, Snodderly DM. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 2008;11:75-83.